DAVID and GOLIATH - Genoma sued by Illumina. Notice of Patent Infringement Proceedings
(Thomson Reuters ONE) -
Geneva, Switzerland - 22 April 2016
We, Genoma SA, (DAVID), Genomics company specialised in Prenatal and Oncology
DNA analysis for early detection and follow-up of genetically
caused diseases, have read in a press release that Illumina Inc. (GOLIATH) and
its wholly-owned subsidiary Verinata Health Inc., have filed a patent
infringement suit against us, Genoma SA, in the Federal Patent Court in
Switzerland. The patents asserted are European Patent (CH) 2 183 693 B1,
European Patent (CH) 0 994 963 B2, European Patent (CH) 1 981 995 B1, and
European Patent (CH) 2 514 842.
The patents are directed to using cell-free fetal DNA for non-invasive prenatal
testing (NIPT).
Genoma's Directors hold a firm belief that Tranquility, a cell-
free fetal DNA, non-invasive test developed by Genoma for early detection of
Down syndrome, as well as other trisomies, like trisomy 13 and trisomy 18, does
not infringe the patents as claimed by Illumina.
The Company will update the market in respect of further developments, as
appropriate.
Genoma is a company of Esperite group.
Patent Infringement 22.4.2016:
http://hugin.info/143308/R/2005898/741086.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Esperite N.V. via GlobeNewswire
[HUG#2005898]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Relevium Technologies Returns 8,612,500 Shares to TreasuryDatum: 22.04.2016 - 12:55 Uhr
Sprache: Deutsch
News-ID 465880
Anzahl Zeichen: 1854
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 255 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DAVID and GOLIATH - Genoma sued by Illumina. Notice of Patent Infringement Proceedings"
steht unter der journalistisch-redaktionellen Verantwortung von
Esperite N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
